Carregant...

Late erythropoiesis‐stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants

BACKGROUND: Preterm infants have low plasma levels of erythropoietin (EPO), providing a rationale for the use of erythropoiesis‐stimulating agents (ESAs) to prevent or treat anaemia. Darbepoetin (Darbe) and EPO are currently available ESAs. OBJECTIVES: To assess the effectiveness and safety of late...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Aher, Sanjay M, Ohlsson, Arne
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2020
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6986694/
https://ncbi.nlm.nih.gov/pubmed/31990982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004868.pub6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!